Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Methylnaltrexone bromide?Carisoprodol manufacturers?Does wegovy have a generic?Buy pfizer brand viagra online?Is there a cheaper alternative to xarelto?
See the DrugPatentWatch profile for Zoryve
Zoryve foam is a topical medicine used on the scalp for plaque psoriasis. It contains roflumilast, a phosphodiesterase 4 (PDE4) inhibitor. [1]
Roflumilast helps reduce inflammatory signaling involved in psoriasis. By inhibiting PDE4, it lowers levels of inflammatory mediators that contribute to plaque formation and redness. [1]
Zoryve foam is applied to affected scalp areas according to the prescribing information and clinician instructions. Proper application technique matters for effectiveness and to avoid irritation. [1]
Common side effects reported with topical roflumilast foam can include application-site reactions such as redness or irritation. Other tolerability details come from the prescribing information and individual trial results. [1]
Zoryve foam is a prescription topical option for scalp psoriasis, typically used when patients and clinicians want a non-steroid approach or need alternatives to other scalp treatments. [1]
Patent and exclusivity details can influence how long competitors are kept off the market and may affect availability and pricing over time. DrugPatentWatch tracks patent/exclusivity-related information for branded drugs like Zoryve and can be a useful reference point for researching those timelines. [2] You can check Zoryve’s patent coverage here: https://www.drugpatentwatch.com/
Other Questions About Zoryve :